Bosnalijek d.d.
🇧🇦Bosnia and Herzegovina
- Country
- 🇧🇦Bosnia and Herzegovina
- Ownership
- Private
- Established
- 1951-01-10
- Employees
- 501
- Market Cap
- -
- Website
- http://bosnalijek.com
Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection
Phase 2
Completed
- Conditions
- COVID-19 Infection
- Interventions
- Drug: The standard of care
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2020-12-24
- Lead Sponsor
- Bosnalijek D.D
- Target Recruit Count
- 120
- Registration Number
- NCT04374032
- Locations
- 🇧🇦
University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina
🇧🇦Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina
🇧🇦Clinical Center University of Sarajevo, Sarajevo, Sarajevo Canton, Bosnia and Herzegovina
A Phase IIIb, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Patients With RRMS
Phase 3
Terminated
- Conditions
- Multiple Sclerosis, Relapsing-Remitting
- Interventions
- Drug: INF beta-1a
- First Posted Date
- 2017-09-14
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Bosnalijek D.D
- Target Recruit Count
- 301
- Registration Number
- NCT03283397
- Locations
- 🇹🇷
Kocaeli University, Faculty of Medicine, Department of Neurology, Kocaeli, Turkey
Efficacy and Safety of the Lysobact Complete Spray®, Tantum Verde® and Pharyngal® Oromucosal Spray in the Treatment of Acute Sore Throat
Phase 3
Completed
- Conditions
- Sore Throat
- Interventions
- Drug: Pharyngal® Oromucosal SprayDrug: Lysobact Complete SpreyDrug: Placebo
- First Posted Date
- 2017-09-13
- Last Posted Date
- 2021-03-16
- Lead Sponsor
- Bosnalijek D.D
- Target Recruit Count
- 346
- Registration Number
- NCT03282045
- Locations
- 🇧🇦
University Clinical Center of the Republic of Srpska, ENT Clinic, Banja Luka, Bosnia and Herzegovina, Banja Luka, Bosnia and Herzegovina
© Copyright 2025. All Rights Reserved by MedPath